Skip to main content
Search results
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-crizotinib-alk-positive-inflammatory-myofibroblastic-tumor
8 months ago -
FDA approves crizotinib for ALK-positive inflammatory myofibroblastic tumor...FDA approves crizotinib for ALK-positive inflammatory myofibroblastic ...
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-burst-edition-fda-approval-xalkori-crizotinib-alk-positive-inflammatory-myofibroblastic
8 months ago -
...14, 2022 FDA approval of Xalkori (crizotinib) for ALK-positive inflammatory myofibroblastic...Edition: FDA approval of Xalkori (crizotinib) for ...
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-burst-edition-xalkori-crizotinib-and-darzalex-faspro-daratumumab-plus-hyaluronidase
8 months ago -
I.S.C.O. Burst Edition: Xalkori (crizotinib) and Darzalex Faspro (daratumumab...January 14, 2021, the FDA approved crizotinib (brand name Xalkori) for ...
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-crizotinib-children-and-young-adults-relapsed-or-refractory-systemic-anaplastic-large
8 months ago -
FDA approves crizotinib for children and young adults with relapsed or refractory...and Drug Administration approved crizotinib (Xalkori, Pfizer Inc.) ...
https://www.fda.gov/news-events/press-announcements/fda-expands-use-xalkori-treat-rare-form-advanced-non-small-cell-lung-cancer
over 1 year ago -
Administration today approved Xalkori (crizotinib) to treat people with advanced (metastatic)...Administration today approved Xalkori (crizotinib) to ...
https://www.fda.gov/drugs/resources-information-approved-drugs/alectinib-approved-alk-positive-metastatic-non-small-cell-lung-cancer-nsclc
8 months ago -
...progressed on or who were intolerant of crizotinib based on an independent review committee...mg orally twice daily (n=152) or crizotinib 250 mg ...
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-ensartinib-alk-positive-locally-advanced-or-metastatic-non-small-cell-lung-cancer
4 months ago -
...randomized 1:1 to receive ensartinib or crizotinib. The main efficacy outcome measure...significant PFS improvement compared to crizotinib with a ...
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-lorlatinib-metastatic-alk-positive-nsclc
8 months ago -
...mg orally once daily (n=149) or crizotinib 250 mg orally twice daily (n=147)...6, 11.1) for those treated with crizotinib. Overall survival data were ...
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-burst-edition-lorbrena-lorlatinib-patients-metastatic-non-small-cell-lung-cancer-whose
8 months ago -
...randomized 1:1 to receive lorlatinib or crizotinib. Study B7461006 demonstrated an improvement...3 months for those treated with crizotinib. Overall ...
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-two-approvals-alk-positive-non-small-cell-lung-cancer
8 months ago -
...progressed on or are intolerant to crizotinib. We will also briefly discuss the...treatment of these patients? SB: Crizotinib, a “first generation” ...
https://www.fda.gov/drugs/fdas-adverse-event-reporting-system-faers/july-september-2024-potential-signals-serious-risksnew-safety-information-identified-fda-adverse
4 months ago -
...tablets Xalkori (crizotinib) capsules Xalkori (crizotinib) oral pellets Severe
https://www.fda.gov/drugs/resources-information-approved-drugs/verified-clinical-benefit-cancer-accelerated-approvals
8 days ago -
NSCLC that has progressed on: • Crizotinib and at least one other ALK inhibitor...progressed or are intolerant to crizotinib 4/28/2017 5/22/2020 ...
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-brigatinib-alk-positive-metastatic-nsclc
8 months ago -
...lead-in at 90 mg once daily (n=137) or crizotinib 250 mg orally twice daily (n=138)...2, 12.9) for those treated with crizotinib (HR 0.49; 95% CI ...
https://www.fda.gov/media/169588/download
almost 2 years ago -
...investigational use: Cabozantinib, Crizotinib, Entrectinib, Larotrectinib, Trametinib...11 Phase 1/2 Trial of Crizotinib in Children Crizotinib oral ...
https://www.fda.gov/drugs/resources-information-approved-drugs/drug-information-soundcast-clinical-oncology-disco
26 days ago -
Edition: Xalkori (crizotinib) FDA approval of Xalkori (crizotinib) for ALK-positive...I.S.C.O. Burst Edition: Xalkori (crizotinib) and Darzalex Faspro ...
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-broadens-ceritinib-indication-previously-untreated-alk-positive-metastatic-nsclc
8 months ago -
...progressed or who are intolerant to crizotinib based on a blinded independent review
https://www.fda.gov/drugs/fdas-adverse-event-reporting-system-faers/october-december-2020-potential-signals-serious-risksnew-safety-information-identified-fda-adverse
about 1 month ago -
... Alunbrig (brigatinib) Xalkori (crizotinib) Zykadia (ceritinib) Photosensitivity
https://www.fda.gov/about-fda/2022-oce-annual-report/oncology-regulatory-review
8 months ago -
...of esophageal squamous carcinoma. Crizotinib for the treatment of ALK-positive...treatment options 7/14/2022 Xalkori (crizotinib) Treatment of adult ...
https://www.fda.gov/drugs/fdas-adverse-event-reporting-system-faers/october-december-2023-potential-signals-serious-risksnew-safety-information-identified-fda-adverse
12 months ago -
...action. Alecensa (alectinib) Xalkori (crizotinib) Acute pancreatitis FDA is evaluating
https://www.fda.gov/media/95302/download
3 months ago -
...progressed on or are intolerant to crizotinib NDA 206545 ORIGINAL-1 ZYDELIG IDELALISIB...progressed on or are intolerant to crizotinib BLA 125514 ...
